🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06668688
Recruiting Observational

Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles @Schule" (i Am Everything @school)

NCT06668688 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-07-05
Last updated
2024-10-31

Condition(s) studied

DepressionDepressive DisorderDepression in ChildrenDepression in Adolescence

Investigational drug(s) / intervention(s)

"ich bin alles @Schule" (i am everything @school; www.schule.ich-bin-alles.de)

"ich bin alles @Schule" (i am everything @school; www.schule.ich-bin-alles.de): The web-based information platform for educational professionals "ich bin alles @Schule" (i am everything @school; www.schule.ich-bin-alles.de) on depression and mental health in childhood and adolescence was developed by the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy at the LMU Munich Hospital together with the Prof. Otto Beisheim Foundation. The website is intended to provide low-threshold information about depression and mental health in the school context.

Study summary

The aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles @Schule". This website for educational professionals offers information on depression and mental health of pupils. Another aim of this study is to determine whether the desired target groups of the website can be reached.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 40 seconds Website-use Exclusion Criteria: \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
LMU University Hospital (recruitment is conducted online) Munich Germany Recruiting

More Ludwig-Maximilians - University of Munich trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06668688 on ClinicalTrials.gov ↗ ← All trials in Germany